HEADLINE
Inocras closed a $31 million Series B-3 round to bring its whole-genome cancer diagnostics platform into U.S. hospitals. The raise underscores investor confidence in Korea’s genomics sector and marks one of the largest healthtech rounds in recent months.


Read full story →
ECOSYSTEM NEWS
Selectstar passed the KOSDAQ technical review for its AI trustworthiness evaluation platform, targeting a year-end listing application. If successful, it would mark Korea’s first public offering centered on AI model governance and explainability—a signal that regulatory and enterprise demand for AI oversight tools is maturing.
Read more →